REVIEW
|
doi:10.20944/preprints201911.0264.v1
Subject:
Medicine And Pharmacology,
Endocrinology And Metabolism
Keywords:
cardiovascular risk; dipeptidyl peptidase-4 inhibitors; glucagon like peptide-1 receptor agonists; sodium glucose cotransporter-2 inhibitors; type 2 diabetes mellitus
Online: 24 November 2019 (04:26:47 CET)